Table 1.

AIF dependence is related to metabolic phenotype [53] and sensitivity to glycolytic inhibition in pancreatic cancer cells

	Relative metabolic phenotype [53]		Sensitivity to glycolytic disruption	Sensitivity to AIF ablation
	Glycolysis/PPP	Fatty acid/ OXPHOS
PANC-1	Moderate	Moderate	Insensitive	Sensitive
BxPC-3	Moderate	Moderate	Insensitive	Sensitive
HPAC	Low	High	Insensitive	Sensitive
HPAF-II	High	Moderate	Moderately sensitive	Moderately sensitive
MIA PaCa-2	High	Low	Sensitive	Insensitive